Nonneutralizing antibodies in haemophilia A patients: to be ignored or not to be!
Nonneutralizing antibodies in haemophilia A patients: to be ignored or not to be!
Background: the existence of nonneutraluzing antibodies (NNAs) to factor VIII (FVIII) unrecognized by the clot-based Bethesda assay has been widely accepted. They are reported both in haemophilia A (HA) patients without inhibitors and healthy controls, but are poorly studied.
Aim: the article discusses the contradictory reports on the nature and clinical significance of NNAs.
Discussion and conclusion: initially defined as antibodies to non-functional domains of FVIII, recent studies have provided evidence for multi-domain specificities. Subclass analysis and affinity studies have shown evidence for distinct immune regulatory pathways which lead to antibody responses against FVIII in different groups. Their role in pharmacokinetics of FVIII is the most frequently studied, while few studies also indicate their possible role as biomarkers for future development of neutralizing antibodies (inhibitors). The impact of NNAs on the clinical severity of HA is largely elusive; however, they can cause difficulties in the interpretation of immunological tests. There is a need for longitudinal comprehensive studies in HA patients on the natural history of NNAs and also for clear guidelines for accurate diagnosis. Present review summarizes the data available on the prevalence of NNAs, their clinical impact and discusses directions for future research.
ELISA, Nijmegen modified Bethesda assay, factor VIII binding antibodies, haemophilia, inhibitors to factor VIII, neutralizing antibodies, nonneutralizing antibodies
Shetty, Shrimati
f72fb053-28ff-456a-8c56-b50bfa8ec779
Dhawlarker, Anam
9779603d-f4de-4a83-b809-68f721a61807
Kharat, Shruti
f2b3a271-b6dc-487e-9736-6835896f8ac5
Patil, Kranti
42f3207b-fd7a-42cf-b378-0e2dbfa69195
Saini, Gurpreet Kaur
5b977594-85f4-4644-8564-4612407494ad
Jivani, Fiza
6159e2ed-3668-45f0-a153-954f8a17ba58
Bharankar, Juili
0dfb2a0b-ebaa-4086-b393-a6c7d49a0ad9
Kshirsagar, Shrinath
8205659d-f877-420f-a6a7-1c34432b4cc4
Rangarajan, Savita
9a5e4c7e-55ba-4a3a-b5f6-f1e269d927c3
Shetty, Shrimati
f72fb053-28ff-456a-8c56-b50bfa8ec779
Dhawlarker, Anam
9779603d-f4de-4a83-b809-68f721a61807
Kharat, Shruti
f2b3a271-b6dc-487e-9736-6835896f8ac5
Patil, Kranti
42f3207b-fd7a-42cf-b378-0e2dbfa69195
Saini, Gurpreet Kaur
5b977594-85f4-4644-8564-4612407494ad
Jivani, Fiza
6159e2ed-3668-45f0-a153-954f8a17ba58
Bharankar, Juili
0dfb2a0b-ebaa-4086-b393-a6c7d49a0ad9
Kshirsagar, Shrinath
8205659d-f877-420f-a6a7-1c34432b4cc4
Rangarajan, Savita
9a5e4c7e-55ba-4a3a-b5f6-f1e269d927c3
Shetty, Shrimati, Dhawlarker, Anam, Kharat, Shruti, Patil, Kranti, Saini, Gurpreet Kaur, Jivani, Fiza, Bharankar, Juili, Kshirsagar, Shrinath and Rangarajan, Savita
(2026)
Nonneutralizing antibodies in haemophilia A patients: to be ignored or not to be!
Haemophilia.
(doi:10.1111/hae.70322).
Abstract
Background: the existence of nonneutraluzing antibodies (NNAs) to factor VIII (FVIII) unrecognized by the clot-based Bethesda assay has been widely accepted. They are reported both in haemophilia A (HA) patients without inhibitors and healthy controls, but are poorly studied.
Aim: the article discusses the contradictory reports on the nature and clinical significance of NNAs.
Discussion and conclusion: initially defined as antibodies to non-functional domains of FVIII, recent studies have provided evidence for multi-domain specificities. Subclass analysis and affinity studies have shown evidence for distinct immune regulatory pathways which lead to antibody responses against FVIII in different groups. Their role in pharmacokinetics of FVIII is the most frequently studied, while few studies also indicate their possible role as biomarkers for future development of neutralizing antibodies (inhibitors). The impact of NNAs on the clinical severity of HA is largely elusive; however, they can cause difficulties in the interpretation of immunological tests. There is a need for longitudinal comprehensive studies in HA patients on the natural history of NNAs and also for clear guidelines for accurate diagnosis. Present review summarizes the data available on the prevalence of NNAs, their clinical impact and discusses directions for future research.
Text
Nonneutralizing antibodies in haemophilia A patients: to be ignored or not to be!
- Author's Original
Restricted to Repository staff only until 30 May 2027.
Request a copy
More information
Accepted/In Press date: 19 May 2026
e-pub ahead of print date: 30 May 2026
Keywords:
ELISA, Nijmegen modified Bethesda assay, factor VIII binding antibodies, haemophilia, inhibitors to factor VIII, neutralizing antibodies, nonneutralizing antibodies
Identifiers
Local EPrints ID: 513198
URI: https://eprints.soton.ac.uk/id/eprint/513198
ISSN: 1351-8216
PURE UUID: cd44d715-4995-463b-8121-68c210a6467c
Catalogue record
Date deposited: 07 Aug 2026 13:36
Last modified: 13 Sep 2026 15:50
Export record
Altmetrics
Contributors
Author:
Shrimati Shetty
Author:
Anam Dhawlarker
Author:
Shruti Kharat
Author:
Kranti Patil
Author:
Gurpreet Kaur Saini
Author:
Fiza Jivani
Author:
Juili Bharankar
Author:
Shrinath Kshirsagar
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics